Fair pricing of old orphan drugs: Considerations for Canada's orphan drug policy

Eve A. Roberts; Matthew Herder; Aidan Hollis

doi:10.1503/cmaj.140308

Fair pricing of old orphan drugs: Considerations for Canada's orphan drug policy

Eve A. Roberts, Matthew Herder, Aidan Hollis

Psychology

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	422-425
Number of pages	4
Journal	CMAJ
Volume	187
Issue number	6
DOIs	https://doi.org/10.1503/cmaj.140308
Publication status	Published - Apr 7 2015

ASJC Scopus Subject Areas

General Medicine

Access to Document

10.1503/cmaj.140308

Cite this

@article{719a82d9dc6447469445102e65d00467,

title = "Fair pricing of old orphan drugs: Considerations for Canada's orphan drug policy",

author = "Roberts, {Eve A.} and Matthew Herder and Aidan Hollis",

note = "Funding Information: Matthew Herder{\textquoteright}s research on orphan drug policy has been supported by a grant from Genome Canada. Aidan Hollis acknowledges the support of the Canadian Institutes of Health Research through a grant on “Developing Effective Policies for Managing Technologies for Rare Diseases.” Funding Information: Competing interests: Eve Roberts has received personal fees from Clarion Healthcare for a consultation about potential new drugs for Wilson disease. Aidan Hollis reports grants from the Canadian Institutes of Health Research and the European Research Council. No competing interests were declared by Matthew Herder. ",

year = "2015",

month = apr,

day = "7",

doi = "10.1503/cmaj.140308",

language = "English",

volume = "187",

pages = "422--425",

journal = "CMAJ",

issn = "0820-3946",

publisher = "Canadian Medical Association",

number = "6",

}

TY - JOUR

T1 - Fair pricing of old orphan drugs

T2 - Considerations for Canada's orphan drug policy

AU - Roberts, Eve A.

AU - Herder, Matthew

AU - Hollis, Aidan

N1 - Funding Information: Matthew Herder’s research on orphan drug policy has been supported by a grant from Genome Canada. Aidan Hollis acknowledges the support of the Canadian Institutes of Health Research through a grant on “Developing Effective Policies for Managing Technologies for Rare Diseases.” Funding Information: Competing interests: Eve Roberts has received personal fees from Clarion Healthcare for a consultation about potential new drugs for Wilson disease. Aidan Hollis reports grants from the Canadian Institutes of Health Research and the European Research Council. No competing interests were declared by Matthew Herder.

PY - 2015/4/7

Y1 - 2015/4/7

UR - http://www.scopus.com/inward/record.url?scp=84926657776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926657776&partnerID=8YFLogxK

U2 - 10.1503/cmaj.140308

DO - 10.1503/cmaj.140308

M3 - Article

C2 - 25712953

AN - SCOPUS:84926657776

SN - 0820-3946

VL - 187

SP - 422

EP - 425

JO - CMAJ

JF - CMAJ

IS - 6

ER -

Fair pricing of old orphan drugs: Considerations for Canada's orphan drug policy

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this